Incisive Health

🚨 Last chance to register for "All Cards on the Table – EU Health Policy from 2025"!   The countdown is nearly over – registrations close tomorrow! Don’t miss this opportunity to join leading EU health policy experts and engage in discussions about the future of healthcare in Europe.   🗣️ Hear from: Pernille Weiss-Ehler, former MEP and Rapporteur for the General Pharmaceutical Legislation Anne Bucher, Bruegel Non-Resident Fellow and former DG SANTE Director-General Annabel Seebohm, LL.M., Secretary General of COCIR   Moderated by our Senior Counsel, Hans Martens, the panel will explore key challenges and opportunities shaping the next era of health policy.   End the day with a networking reception – the perfect chance to connect with fellow attendees and industry leaders as we look ahead to 2025.   🗓️ Date: Wednesday, 4 December 📍 Location: COMET Louise, Brussels   ⏳ Register now before it's too late: https://bit.ly/4f871cv

🚨 Last week to register for “All Cards on the Table – Health Policy from 2025” 🇪🇺 The countdown is on! Only one week left to register for our “All Cards on the Table – EU Health Policy from 2025” event. Time to secure your spot https://bit.ly/4f871cv. Join us and a panel of top EU health policy experts, moderated by our Senior Counsel, Hans Martens, to discuss the challenges and opportunities that lie ahead for healthcare in Europe. 🗣️Pernille Weiss-Ehler, former MEP and Rapporteur for the General Pharmaceutical Legislation
 🗣️Anne Bucher, Bruegel Non-Resident Fellow and former DG SANTE Director-General
 🗣️Annabel Seebohm, LL.M., Secretary General of COCIR And after the panel, end the day with a networking reception - a perfect opportunity to make connections as we look ahead to the new year. 📍 Location: COMET Louise, Brussels
 🗓️ Date: Wednesday, 4 December Secure your place now https://bit.ly/4f871cv

🌏 Looking for a good read this lunchtime? Check out our latest blog, by Thomas Micklem, which looks back at #COP29 and explores what lies ahead for climate change and health https://lnkd.in/dYwd8ZFF #climatechange #globalhealthpolicy

Yesterday Incisive Health convened women’s health policy, clinical and patient experts at a breakfast event exploring how we can “find the balance” in NHS menopause care. Attendees reflected on progress made since the publication of the 2022 Women’s Health Strategy, and considered the steps the new government can take to improve the experiences of women from all communities as they navigate the menopause. Key topics of discussion included: 🤝 The importance of join-up between different parts of the health system, at key touchpoints - particularly for women experiencing surgically-induced early menopause ℹ️ How we can provide information about menopause, at the right time - and the potential role of technology and AI 🧩 Opportunities to strengthen the ongoing national roll-out of Women’s Health Hubs to fulfil their potential to provide holistic and individualised menopause care Thank you to all attendees for joining a positive and productive discussion, and particularly to Janet Barter, President of the FSRH - Faculty of sexual and reproductive healthcare for skilfully chairing the event, and to Shireen Noor for joining the expert panel to highlight the importance of understanding cultural, religious and psychological perspectives of menopause, alongside our own Laura Tantum. Watch this space for a blog outlining headline themes from the discussion in further detail, and attendees’ recommendations for the new government. In the meantime, reach out to womenshealth@incisivehealth.com to find out more about our women’s health expertise, across our UK and international practices.

🇪🇺Incisive Health is attending the European Cancer Summit 2024, organised by European Cancer Organisation. This event brings together distinguished experts, policymakers, and advocates to address key challenges in cancer care, including prevention, early detection, screening, and critical topics like the healthcare workforce, health systems, and the future of Europe’s Beating Cancer Plan. 💬 At the opening session, "United Against Cancer Inequalities: Forging Fair Cancer Outcomes for All”, health inequalities took center stage, with a strong focus on gender disparities and advancing women’s health. A key highlight is the presentation of ECO’s paper on Women and Cancer, which calls for: • Expanding free HPV vaccinations and access to breast and gynecological cancer screening. • Ensuring harmonised cancer care standards across Europe. • Supporting women caregivers through better policies and flexible work arrangements. • Promoting gender equity in health systems and clinical trials. 🤝 Curious to learn more? Reach out to our team for a chat! 

🎙️ Meet the panellists of our next #BreaktheBubble event 🇪🇺 “All Cards on the Table – EU Health Policy from 2025” (https://bit.ly/4f871cv) is just around the corner. Time to get an inside perspective on our panellists. Earlier this year, they each joined us on our #BreaktheBubble podcast, to talk pharma legislation, EU elections, evolution of health policy and innovation in Europe, and more. You can catch the full conversations here:
 🔗 Annabel Seebohm, LL.M. takes us through COCIR’s vision for health policy and the work of its highly innovative members https://bit.ly/4emI8se (Published on Nov 06, 2024) 🔗 Pernille Weiss-Ehler talks about the GPL and its broader impact on health policy https://bit.ly/4674YSe (Published on Jul 17, 2024) 🔗 Anne Bucher discusses the potential impact of the EU elections on health policy https://spoti.fi/3UFpmGk (Published on Feb 15, 2024) 🚨 More to come in December and don’t forget that seats are limited. Don’t miss your chance to engage with these experts in person! Register now to secure your seat and join the live discussion. All info here: https://bit.ly/4f871cv

🇪🇺 A few days after the event, and after taking time to digest the discussions and the insights shared, one thing is clear: collaboration and commitment are driving us closer to a future where Precision Oncology is accessible to all across Europe.   A huge thank you to EFPIA - European Federation of Pharmaceutical Industries and Associations, EUREGHA - European Regional and Local Health Authorities, and the Committee of the Regions for hosting such an impactful event, and to all the stakeholders who contributed to shaping this crucial conversation.   Key takeaways from the event: 1. Breaking barriers to access: addressing challenges like reimbursement and infrastructure gaps is essential to make personalised cancer care a reality for all. 2. The power of collaboration: regions and local authorities are at the heart of implementing innovative solutions, advancing health systems, and improving outcomes. 3. Policy and practice: a robust legislative framework and sustained funding will be critical to support precision medicine’s integration into healthcare systems. 4. Data and innovation: EU-wide initiatives are paving the way for better use of data and cutting-edge research to drive progress in personalised medicine.   At Incisive Health, we’re proud to have supported this event and played a role in fostering collaboration and dialogue. Now, it’s up to all of us to build on these insights and translate them into meaningful action. Together, we can ensure that precision oncology continues to advance across the EU, improving outcomes for patients everywhere.   Let’s keep the momentum going! 

Approximately 13 million people in the UK (a third of the female population) are currently peri or menopausal. Yet we have only just started talking about menopause in women's health. Next week IH is hosting a breakfast event in London with experts in this field to explore how the new UK government is approaching policies on menopause. See registration details below if you would like to come along!

📅 One week to go until our next London breakfast event, "Finding the balance: how can the NHS best support women throughout menopause?" 📅 On Wednesday 20 November, we are hosting our next breakfast event in central London, exploring opportunities to drive menopause policy reform under the new government. Chaired by Dr Janet Barter, menopause expert and President of the FSRH - Faculty of sexual and reproductive healthcare, the event will seek to reflect on progress made under the Women’s Health Strategy and discuss opportunities to embed a more holistic approach to menopause, considering women's health needs in the round - from the specific needs of women who have undergone cancer treatment, to the importance of adopting cultural sensitivity in our approach to menopause.   The panel event will bring together experts from across the women's health community including patient advocacy groups, professional experts and the pharmaceutical and FemTech industry.    We have a final few spaces remaining for the event - if you'd be interested in attending drop us an email at womenshealth@incisivehealth.com for more information!

🇪🇺 LIVE NOW from the Committee of the Regions! We’re excited to support EFPIA - European Federation of Pharmaceutical Industries and Associations and EUREGHA - European Regional and Local Health Authorities in today’s important discussion on advancing precision oncology in the EU, live from the Committee of the Regions. At Incisive Health, we’re proud to help clients connect the dots in the complex health policy landscape. It’s especially rewarding to see it all come together at events like this, where stakeholders across healthcare join forces toward a shared vision. Can’t be here in person? 👉 Catch the event online https://lnkd.in/dsKHVqxi! Join us for five panels packed with insights from policymakers, regional health leaders, patient advocates, and healthcare providers. They’ll discuss the future of precision oncology in Europe, including opportunities, challenges, and success stories from across the EU. Don’t miss your chance to engage with speakers through live polls and Q&A!